Effect of topical loteprednol etabonate with lid hygiene on tear cytokines and meibomian gland dysfunction in prosthetic eye wearers
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ko, J. S. | - |
dc.contributor.author | Seo, Y. | - |
dc.contributor.author | Chae, M. K. | - |
dc.contributor.author | Jang, S. Y. | - |
dc.contributor.author | Yoon, J. S. | - |
dc.date.accessioned | 2021-08-11T12:43:49Z | - |
dc.date.available | 2021-08-11T12:43:49Z | - |
dc.date.issued | 2018-02 | - |
dc.identifier.issn | 0950-222X | - |
dc.identifier.issn | 1476-5454 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/6251 | - |
dc.description.abstract | Purpose To assess tear cytokine levels and clinical outcomes in meibomian gland dysfunction (MGD) in the blind eye of patients wearing an ocular prosthesis after 2 months of treatment with topical loteprednol etabonate and eyelid scrubs with warm compresses. Patients and methods This study included patients with MGD wearing a unilateral ocular prosthesis for more than 1 year. All patients topically received 0.5% loteprednol etabonate and were instructed to scrub their eyelids with warm compresses on the prosthetic eye for 2 months. We evaluated tear cytokine levels using Multiplex Bead Immunoassays, performed biomicroscopic examination of the lid margins and meibomian gland, conducted meibography imaging, and assessed MGD-related ocular symptoms using a questionnaire for the prosthetic eye before and 2 months after treatment. Results Thirty consecutive patients were included. There were significant reductions in the levels of interleukin (IL)-6, interferon-., monocyte chemotactic protein-1, IL-8, tumor necrosis factor-a, and IL-1 beta (P<0.001 for each cytokine). Moreover, there were improvements in ocular symptoms (P=0.001), lid margin abnormalities (P<0.001), meibomian gland expressibility (P<0.001) and meibography findings (P=0.037). Conclusion Topical loteprednol etabonate in conjunction with eyelid scrubs and warm compresses were effective in treating MGD in prosthetic eye wearers. Furthermore, tear cytokine measurements may serve as an additional approach for evaluating the efficacy of anti-inflammatory treatment for MGD in prosthetic eye wearers. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Nature Publishing Group | - |
dc.title | Effect of topical loteprednol etabonate with lid hygiene on tear cytokines and meibomian gland dysfunction in prosthetic eye wearers | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1038/eye.2017.213 | - |
dc.identifier.scopusid | 2-s2.0-85041799849 | - |
dc.identifier.wosid | 000424650300040 | - |
dc.identifier.bibliographicCitation | Eye, v.32, no.2, pp 439 - 445 | - |
dc.citation.title | Eye | - |
dc.citation.volume | 32 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 439 | - |
dc.citation.endPage | 445 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Ophthalmology | - |
dc.relation.journalWebOfScienceCategory | Ophthalmology | - |
dc.subject.keywordPlus | OCULAR SURFACE DISEASE | - |
dc.subject.keywordPlus | INTERNATIONAL WORKSHOP | - |
dc.subject.keywordPlus | INFLAMMATORY CYTOKINES | - |
dc.subject.keywordPlus | ANOPHTHALMIC SOCKET | - |
dc.subject.keywordPlus | CLINICAL-OUTCOMES | - |
dc.subject.keywordPlus | ARTIFICIAL EYES | - |
dc.subject.keywordPlus | SUBCOMMITTEE | - |
dc.subject.keywordPlus | MODERATE | - |
dc.subject.keywordPlus | TRIAL | - |
dc.subject.keywordAuthor | 안과학 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.